$同源康医药-B(0_老虎社区_美港股上老虎

$同源康医药-B(02410)$ 目前核心研发团队稳定，核心研发和管理团队全部留任，进一步增强了公司核心团队的稳定性，为后续管线推进和商业化落地提供了坚实的组织保障

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":600639027552400,"tweetId":"600639027552400","gmtCreate":1787670030061,"gmtModify":1787670032336,"author":{"id":4218363023229180,"idStr":"4218363023229180","authorId":4218363023229180,"authorIdStr":"4218363023229180","name":"电白小白15","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 目前核心研发团队稳定，核心研发和管理团队全部留任，进一步增强了公司核心团队的稳定性，为后续管线推进和商业化落地提供了坚实的组织保障</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 目前核心研发团队稳定，核心研发和管理团队全部留任，进一步增强了公司核心团队的稳定性，为后续管线推进和商业化落地提供了坚实的组织保障</p></body></html>","text":"$同源康医药-B(02410)$ 目前核心研发团队稳定，核心研发和管理团队全部留任，进一步增强了公司核心团队的稳定性，为后续管线推进和商业化落地提供了坚实的组织保障","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/600639027552400","repostId":0,"isVote":1,"tweetType":1,"viewCount":270,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02410"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":148,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}